Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Prasco Laboratories. The primary component is Phenobarbital; Hyoscyamine Sulfate; Atropine Sulfate; Scopolamine Hydrobromide.
| Product ID | 66993-117_71055144-58e6-4ab5-aea2-d29b45b6761b |
| NDC | 66993-117 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide |
| Generic Name | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate And Scopolamine Hydrobromide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-11-18 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Prasco Laboratories |
| Substance Name | PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE |
| Active Ingredient Strength | 16 mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |